ENBI.CN WACC - Weighted Average Cost of Capital

The WACC of Entheon Biomedical Corp (ENBI.CN) is 21.1%.

The Cost of Equity of Entheon Biomedical Corp (ENBI.CN) is 38.50%.

The Cost of Debt of Entheon Biomedical Corp (ENBI.CN) is 5.00%.

	Range	Selected
Cost of equity	34.90% - 42.10%	38.50%
Tax rate	25.90% - 26.50%	26.20%
Cost of debt	5.00% - 5.00%	5.00%
WACC	19.3% - 22.9%	21.1%

WACC

ENBI.CN WACC calculation

Category	Low	High

Long-term bond rate	3.2%	3.7%
Equity market risk premium	5.1%	6.1%
Adjusted beta	6.22	6.22

Additional risk adjustments	0.0%	0.5%
Cost of equity	34.90%	42.10%

Tax rate	25.90%	26.50%
Debt/Equity ratio	1	1
Cost of debt	5.00%	5.00%

After-tax WACC	19.3%	22.9%


Selected WACC	21.1%

ENBI.CN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ENBI.CN:

cost_of_equity (38.50%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (6.22) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.